Pancreatic Ductal Adenocarcinoma Clinical Trials in New Haven, Connecticut

3 studies are recruiting for pancreatic ductal adenocarcinoma in New Haven, Connecticut right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors combined with Standard(s) of Care (SOC) or with novel agents. The current subprotocols include the following: Subprotocol A: RMC-6236 + 5…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Yale-New Haven Hospital-Yale Cancer Center, New Haven, Connecticut
    Locations
    32 in total
    Run by
    Revolution Medicines, Inc.

    See if you can join NCT06445062 on ClinicalTrials.gov

  2. Pancreatic Cancer Early Detection Consortium

    The purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or individuals carrying…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    Yale University, New Haven, Connecticut
    Locations
    60 in total
    Run by
    Arbor Research Collaborative for Health

    See if you can join NCT04970056 on ClinicalTrials.gov

  3. Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

    The study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have received prior neoadju…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Yale Cancer Center, New Haven, Connecticut
    Locations
    93 in total
    Run by
    Panbela Therapeutics, Inc.

    See if you can join NCT05254171 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.